These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28169116)

  • 81. Evaluation of hemostatic activity of desamino-D-arginine vasopressin (DDAVP) in uremic rats.
    Kaufman S; Stewart M; Gordon PA
    Thromb Res; 1994 Jan; 73(1):53-9. PubMed ID: 8178313
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.
    Andersen LK; Hvas AM; Hvas CL
    Neurocrit Care; 2021 Jun; 34(3):1026-1046. PubMed ID: 32748210
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of Two Weight-Based Desmopressin Dosing Strategies for Spontaneous Bleeding.
    Franquiz MJ; Hines MC; Yeung SYA
    Ann Pharmacother; 2018 Jun; 52(6):527-532. PubMed ID: 29332421
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cost-Effectiveness of POC Coagulation Testing Using Multiple Electrode Aggregometry.
    Straub N; Bauer E; Agarwal S; Meybohm P; Zacharowski K; Hanke AA; Weber CF
    Clin Lab; 2016; 62(6):1167-78. PubMed ID: 27468580
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Con: desmopressin is not of value in the treatment of post-cardiopulmonary bypass bleeding.
    Hackmann T; Naiman SC
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):290-3. PubMed ID: 1863751
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Control of postoperative bleeding in the cardiac surgery patient.
    Brown MM; Kemper KM
    J Cardiovasc Nurs; 1993 Jul; 7(4):59-70. PubMed ID: 8326363
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Minimal invasive extracorporeal circulation preserves platelet function after cardiac surgery: a prospective observational study.
    Argiriadou H; Antonitsis P; Gkiouliava A; Papapostolou E; Deliopoulos A; Anastasiadis K
    Perfusion; 2020 Mar; 35(2):138-144. PubMed ID: 31378133
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin.
    Alonso DF; Ripoll GV; Garona J; Iannucci NB; Gomez DE
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1974-80. PubMed ID: 21470136
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Desmopressin and bleeding risk after percutaneous kidney biopsy.
    Athavale A; Kulkarni H; Arslan CD; Hart P
    BMC Nephrol; 2019 Nov; 20(1):413. PubMed ID: 31730448
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.
    Gunther M; Witenko CJ; Prust M; Salerno D; Berger K
    J Intensive Care Med; 2022 Jun; 37(6):825-832. PubMed ID: 34286612
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Use of Desmopressin (DDAVP) After a Nontraumatic Intracerebral Hemorrhage.
    Gajdosik DA; Rosini JM
    J Emerg Nurs; 2016 Nov; 42(6):541-543. PubMed ID: 27912810
    [No Abstract]   [Full Text] [Related]  

  • 93. Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: a systematic review.
    Lim CC; Tan HZ; Tan CS; Healy H; Choo J; Franca Gois PH
    Intern Med J; 2021 Apr; 51(4):571-579. PubMed ID: 32040251
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Desmopressin control of surgical hemorrhage secondary to prolonged bleeding time.
    Sieber PR; Belis JA; Jarowenko MV; Rohner TJ
    J Urol; 1988 May; 139(5):1066-7. PubMed ID: 3361648
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of desmopressin acetate on acute spontaneous intracranial hemorrhage in patients on antiplatelet therapy.
    McManus J; Ferreira J; Jones GM; Smetana KS; Smith Condeni M; Berger K; Witenko C; Smotherman C; Gautam S; Pizzi MA; Erdman MJ
    J Neurol Sci; 2022 Mar; 434():120142. PubMed ID: 35081458
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perioperative Factor Concentrate Use is Associated With More Beneficial Outcomes and Reduced Complication Rates Compared With a Pure Blood Product-Based Strategy in Patients Undergoing Elective Cardiac Surgery: A Propensity Score-Matched Cohort Study.
    Nemeth E; Varga T; Soltesz A; Racz K; Csikos G; Berzsenyi V; Tamaska E; Lang Z; Molnar G; Benke K; Eory A; Merkely B; Gal J
    J Cardiothorac Vasc Anesth; 2022 Jan; 36(1):138-146. PubMed ID: 33941446
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Safety of renal biopsy bleeding prophylaxis with desmopressin.
    Barrios RHS; Burguera Vion V; Álvarez Nadal M; Cintra Cabrera M; Elías Triviño S; Villa Hurtado D; Ortego S; Fernández Lucas M; Rivera-Gorrin M
    J Int Med Res; 2021 Sep; 49(9):3000605211040764. PubMed ID: 34590925
    [TBL] [Abstract][Full Text] [Related]  

  • 98. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery.
    Capraro L; Kuitunen A; Salmenperä M; Kekomäki R
    Acta Anaesthesiol Scand; 2001 Feb; 45(2):200-6. PubMed ID: 11167166
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Desmopressin and bleeding.
    Bidstrup BP; Royston D
    Anaesthesia; 1989 Dec; 44(12):1009. PubMed ID: 2619003
    [No Abstract]   [Full Text] [Related]  

  • 100. Easy bruisability, aspirin intolerance, and response to DDAVP.
    Lekas MD; Crowley JP
    Laryngoscope; 1993 Feb; 103(2):156-9. PubMed ID: 8426506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.